Immunity
The body defends itself against microbes with three lines of defence. The first (skin and mucous membranes) and second (phagocytes, NK cells, complement, interferons, inflammation and fever) lines are nonspecific and make innate immunity. The third line is specific: B cells make antibodies and T cells carry out the cell-mediated response, giving memory and long-term protection. The unit also covers monoclonal antibodies, acquired immunity, vaccination, immune disorders and transplant rejection.
Learning outcomes (23)
- List the structural features of human skin that make it an impenetrable barrier against invasion by microbes. (1st line of defence).
- Explain how oil and sweat glands within the epidermis inhibit the growth and also kill microorganisms. (1st line of defence).
- Recognize the role of the acids of the digestive tract as killing bacteria present in food.
- State the role of the ciliated epithelium of the nasal cavity and the mucous of the bronchi and bronchioles in trapping airborne microorganisms.
- Describe the role of macrophages and neutrophils in killing bacteria.
- Explain how Natural Killer (NK) cells kill cells infected by microbes and cancer cells.
- State the way proteins of the complement system kill bacteria and that interferons inhibit viruses from infecting cells.
- State the events of the inflammatory response as a generalized, nonspecific defence.
- Outline the release of pyrogens by microbes and their effect on the hypothalamus to boost the body's temperature.
- List the ways that fever affects microbes.
- Define the specific immune system as providing specific defence and acting as the most powerful means of resisting infection.
- Identify monocytes, T cells, and B-cells as components of the immune system.
- State inborn and acquired immunity as the two basic types of immunity.
- Differentiate between active and passive immunity as the two types of acquired immunity.
- Describe the role of T-cells in cell-mediated immunity.
- Describe the role of B-cells in antibody-mediated immunity.
- Discuss the role of T-cells and B-cells in transplant rejections.
- Evaluate the discovery of monoclonal antibodies and justify how this accomplishment revolutionized many aspects of biological research.
- Identify the process of vaccination as a means to develop active acquired immunity.
- Draw the structural model of an antibody molecule.
- Explain the role of memory cells in long term immunity.
- Define allergies and correlate the symptoms of allergies with the release of histamines.
- Describe the autoimmune diseases with examples.
Introduction to immunity
You have met immunity in earlier classes. This chapter looks at how the body defends itself, with most emphasis on the immune system. The body's response to foreign particles, such as the production of antibodies directed against one particular antigen, is called an immune response.
- Immune response
- The body's response to foreign particles, such as the production of antibodies directed against a specific antigen.
- Immunity
- The ability to resist damage from foreign substances such as microorganisms and harmful chemicals, for example toxins released by microorganisms.
- Immunology
- The study of foreign particles that can affect the living body and of the defence mechanisms the body uses to eliminate them.
The human body has three lines of defence against microbial attack.
- First line: external barriers that keep microbes out of the body.
- Second line: nonspecific internal defence that combats all invading microbes.
- Third line: specific internal defence, also called adaptive or acquired immunity.
The first and second lines of defence together make innate immunity. The third line is adaptive (acquired) immunity.
| Line of defence | Nature | What it consists of |
|---|---|---|
| First | Nonspecific, external | Skin and mucous membranes (mechanical and chemical barriers, reflexes) |
| Second | Nonspecific, internal | Phagocytic cells, natural killer cells, protective proteins, inflammatory response, fever |
| Third | Specific, internal | Cell-mediated response (T cells) and humoral response (B cells and antibodies) |
9.1First line of defence
The first and obviously best defence is to keep microbes out in the first place. The human body has two surfaces exposed to the environment: the skin, and the mucous membranes of the digestive and respiratory tracts. These surfaces are external barriers to microbial invasion.
Because these barriers inhibit nearly all kinds of microbes in the same way, the first line of defence is a nonspecific defence.
| Barrier | Where | How it protects |
|---|---|---|
| Skin | Outer body surface | Tightly packed keratinised cells, dry dead surface, acidic pH, sebum, sweat |
| Mucous membrane of the digestive tract | Lining of the gastrointestinal tract (GIT) | Hydrochloric acid and digestive enzymes kill bacteria in food |
| Mucous membrane of the respiratory tract | Nasal cavity, trachea, bronchi, bronchioles | Hairs, mucus and cilia trap particles and sweep them towards the pharynx |
9.1.1Skin: an impenetrable barrier against microbial invasionOften examined
The skin is made of two layers, the epidermis and the dermis. Together they give a physical, a chemical and an immune barrier, so unbroken skin blocks microbes extremely well.
Epidermis: the physical barrier
- The epidermis is the outermost layer, made of tightly packed cells that form a physical barrier.
- Most epidermal cells contain the protein keratin, which strengthens them and makes them resistant to abrasion and water loss.
- The outer surface consists of dry dead cells, so most microbes that land on it cannot get the water and nutrients they need.
- The surface has a slightly acidic pH (around 5.5), which inhibits the growth of many pathogens.
- Desquamation is the shedding of dead skin cells. It removes microbes that have attached to the surface.
Dermis: glands and the immune barrier
The dermis is the inner, comparatively thick layer. It contains glands, hair follicles, receptors, nerves and blood vessels.
- Sebaceous (oil) glands secrete sebum, an oily substance. Sebum contains fatty acids that lower skin pH and have antimicrobial properties.
- Sweat glands secrete sweat, a salty fluid that generally cools the body. Sweat contains lysozyme, an enzyme that breaks down bacterial cell walls, and its high salt concentration can dehydrate bacteria.
- Secretions from sweat and sebaceous glands contain natural antibiotics such as lactic acid, which inhibit the growth of bacteria and fungi.
| Structural feature | How it defends against microbes |
|---|---|
| Tightly packed keratinised cells | Physical barrier; resist abrasion and water loss |
| Dry dead outer cells | Microbes cannot get water and nutrients |
| Acidic surface pH (about 5.5) | Inhibits growth of many pathogens |
| Desquamation | Shedding of dead cells removes attached microbes |
| Sebum (fatty acids) | Lowers skin pH; antimicrobial |
| Sweat (lysozyme, salt, lactic acid) | Lysozyme digests bacterial cell walls; salt dehydrates bacteria; lactic acid inhibits bacteria and fungi |
| Sebaceous gland | Sweat gland |
|---|---|
| Secretes oily sebum | Secretes salty sweat |
| Sebum has fatty acids that lower skin pH | Sweat contains lysozyme and a high salt concentration |
| Antimicrobial by acidity and fatty acids | Breaks down bacterial walls, dehydrates bacteria; lactic acid inhibits bacteria and fungi |
| Lies in the dermis, beside the hair follicle | Lies in the dermis; its secretion reaches the skin surface |
9.1.2Epithelium of digestive tract: an impenetrable barrier against microbial invasion
The gastrointestinal tract (GIT) is covered by a mucous membrane. This protects the GIT against microbial invasion by means of its various secretions.
- Hydrochloric acid is secreted in the stomach by the oxyntic (parietal) cells. It kills the bacteria present in food.
- Various digestive enzymes in gastric juice, intestinal juice and pancreatic juice also digest the bacteria present in food.
| Secretion | Where it is made | Defensive action |
|---|---|---|
| Hydrochloric acid | Oxyntic (parietal) cells of the stomach | Kills bacteria present in food |
| Digestive enzymes | Gastric, intestinal and pancreatic juices | Digest the bacteria present in food |
9.1.3Epithelium of respiratory tract: an impenetrable barrier against microbial invasion
The anterior (front) part of the nasal cavities, which contains hairs, is called the vestibule. The respiratory tract defends itself in the following ways.
- Vestibular hairs filter the large dust particles from inhaled air.
- The inner surface of the nasal cavities is lined with ciliated mucous epithelium. Its mucus traps fine dust particles and microbes.
- The cilia of this epithelium sweep the trapped fine dust and microbes backwards to the pharynx, where they are swallowed and eliminated by the digestive system.
- The trachea and the air passages inside the lungs (bronchi and bronchioles) are also lined with ciliated mucous epithelium. Its cilia propel mucus and foreign particles towards the larynx, where they enter the pharynx and are swallowed.
- Microbes and dust enter with inhaled air.
- Hairs of the vestibule filter large particles; mucus of the epithelium traps the fine particles and microbes.
- Cilia beat and sweep the mucus upwards along the airway towards the pharynx.
- The mucus is swallowed and the microbes are eliminated by the digestive system.
9.2Second line of defence: nonspecific defenceOften examined
If microbes succeed in penetrating the skin or mucous membranes, a second line of defence takes action. It is made up of nonspecific internal defences.
- A standing army of phagocytic cells and natural killer cells.
- The inflammatory response, provoked by the invasion of microbes.
- Fever, which the body often produces.
- Protective proteins (the complement system and interferons).
These defences are nonspecific because they attack a wide variety of microbes, rather than targeting specific invaders as the immune response does.
| Component | Section |
|---|---|
| Phagocytes (macrophages, dendritic cells, neutrophils) and NK cells | 9.2.1 Killing cells of blood |
| Complement proteins and interferons | 9.2.2 Protective proteins |
| Inflammatory response | 9.2.3 |
| Fever | 9.2.4 Temperature response |
9.2.1Killing cells of bloodOften examined
Some white blood cells are called phagocytes. A phagocyte is a cell that destroys other abnormal body cells (cancerous cells) or invaded microorganisms by engulfing them. This process is called phagocytosis.
The main phagocytic white blood cells are macrophages, dendritic cells and neutrophils. Natural killer (NK) cells kill infected body cells and cancer cells in a different way, by releasing proteins.
| Cell | Belongs to | Main job |
|---|---|---|
| Macrophage | Phagocytes (from monocytes) | Engulfs and digests microbes; displays antigens (APC); secretes proteins |
| Dendritic cell | Phagocytes (from monocytes) | Antigen-presenting cell that activates T cells |
| Neutrophil | Phagocytes (granulocyte) | Rapid, short-lived phagocytosis; degranulation; extracellular traps |
| NK cell | Lymphocyte, innate immunity | Kills cancer cells and virus-infected cells with perforins and granzymes |
9.2.1Macrophages and dendritic cellsOften examined
Monocytes are formed in the bone marrow. They typically circulate in the blood for 1 to 3 days before migrating into the tissues, where they become macrophages or dendritic cells. Through the blood, macrophages and dendritic cells are carried to the areas of the body where they are needed.
Macrophages
- Macrophages are generally found in organs such as the lungs, liver, spleen, kidney and lymph nodes, not in the blood. There they patrol within the free spaces among the cells and trap and destroy microorganisms entering the tissue.
- As macrophages interact with microbes they engulf and destroy them, and they also display some parts of the microbes on their surface so that other body cells may be informed. Such cells are called antigen presenting cells (APCs).
- During phagocytosis macrophages secrete many proteins. Some trigger the maturation of monocytes into macrophages, increasing their number. Interleukin-1 signals the brain to raise the body temperature, producing fever. Some other proteins stimulate the specific immune response.
- Macrophages also play an essential role in wound healing and tissue repair by removing dead cells and debris.
Dendritic cells
Dendritic cells (DCs) are found in tissue that is in contact with the outside environment. They become antigen-presenting cells that capture, process and present antigens to lymphocytes to initiate and regulate the adaptive immune response.
9.2.1NeutrophilsOften examined
Neutrophils belong to the granulocyte type of white blood cells.
- They are highly short-lived and highly mobile: they squeeze between the cells of capillary walls and can enter parts of tissue where other cells cannot.
- They move like Amoeba, forming pseudopodia.
- They proceed rapidly to the infected area and often die after a single phagocytic event.
- Neutrophils also release lysosomal enzymes by extracellular degranulation; these kill microorganisms and cause inflammation.
- Neutrophils can release neutrophil extracellular traps (NETs) to kill microbes.
| Macrophages | Neutrophils |
|---|---|
| Develop from monocytes; found in tissues and organs (lungs, liver, spleen, kidney, lymph nodes) | Granulocytes of the blood; squeeze out of capillaries into tissue |
| Patrol the free spaces among tissue cells | Short-lived; often die after one phagocytic event |
| Display microbial parts: act as antigen presenting cells; secrete proteins (interleukin-1) | Release lysosomal enzymes (degranulation) and extracellular traps |
9.2.1Natural killer cellsOften examined
Natural killer (NK) cells are a type of lymphocyte that provide innate immunity. In general, NK cells do not directly attack invading microbes. Instead they attack cancerous cells and body cells infected by viruses.
An NK cell kills its target by releasing proteins called perforins. The pores formed by these proteins allow certain apoptotic proteases, known as granzymes, to diffuse passively into the target cell. The cell then dies by apoptosis, and a macrophage engulfs and digests the dying cell.
- Perforins
- Proteins released by NK cells that punch holes in the membrane of an infected or cancerous cell.
- Granzymes
- Apoptotic proteases that enter the target cell through the perforin pores and make it die by apoptosis.
- Apoptosis
- Programmed death of a cell.
- The NK cell meets a virus-infected or cancerous cell and releases perforins.
- The perforins form a hole (pore) in the membrane of the enemy cell.
- Granzymes from the NK cell diffuse through the hole into the enemy cell.
- The granzymes start apoptosis, so the enemy cell dies.
- A macrophage engulfs and digests the dying cell.
9.2.2Protective proteins of complement systemOften examined
The complement system consists of over fifty types of small proteins found in the blood. They are synthesised by the liver and normally circulate in an inactive state. They are activated when foreign particles enter the body.
Once one complement protein is activated, it activates another protein, which activates other proteins of the system, and so on. As a result:
- phagocytes clear foreign and damaged material;
- inflammation develops, which attracts additional phagocytes to the site of infection;
- cell-killing membrane attack complexes are activated.
The complement system is an important supporter of the immune system. It enhances (complements) the ability of antibodies and phagocytic cells to clear microbes and damaged cells from the body, promotes inflammation, and attacks the plasma membrane of the pathogen.
An example of the protective proteins of the complement system is the membrane attack complex (MAC). It produces holes in the bacterial cell wall and the plasma membrane of pathogens. The holes allow fluids and salts to enter the bacterial cell, so the bacterium swells and eventually bursts.
- Complement proteins, inactive in the blood, are activated by foreign particles.
- Each activated protein activates the next, so the effect is passed on in a chain.
- Activated proteins form a membrane attack complex that makes holes in the cell wall and plasma membrane of the bacterium.
- Water and salts diffuse into the bacterium through the holes.
- The bacterium swells and bursts.
9.2.2InterferonsOften examined
Interferons belong to the large class of proteins known as cytokines, molecules used for communication between cells during infection. They are released by host cells in response to several pathogens, especially viruses. Interferons are named for their ability to "interfere" with viral replication.
Interferons are antiviral agents produced by virus-infected cells. On infection, virus-infected cells mount an innate immune response to protect themselves from the virus and to warn neighbouring cells by means of interferon.
Interferons have a wide range of functions used to combat infection at all stages of a pathogen's life cycle. For a viral infection they:
- signal virus-infected cells to undergo apoptosis;
- prohibit entry of the virus into uninfected cells;
- stop viral replication;
- prevent the virus from leaving an infected cell;
- activate immune cells to generate an immune response.
The many forms of interferon are rapidly produced to defend against viruses. Interferons can also combat bacterial and parasitic infections, inhibit cell division, and promote or slow down the differentiation of cells.
| Target of interferon | Effect |
|---|---|
| Uninfected neighbouring cells | Destroy RNA and reduce protein synthesis, so the virus cannot multiply |
| Infected neighbouring cells | Undergo apoptosis |
| Immune cells | Activated to generate an immune response |
9.2.3Inflammatory responseOften examined
The inflammatory response is a major component of the nonspecific defence. Any damage to tissue, whether caused by an infectious microorganism or by physical injury, even just a scratch or an insect bite, triggers this response. Inflammation can be localised or systemic (widespread).
- Local inflammation
- An inflammatory response confined to a specific area of the body.
The classical signs of inflammation are heat, pain, redness, swelling and loss of function.
Figure 9.10 shows the chain of events when a pin has pricked the skin and infected it with bacteria. The first thing that happens is that the damaged cells release chemical alarm signals such as histamine. The chemical sparks the mobilisation of various defences. Histamine induces neighbouring blood vessels to dilate and to start leaking. Blood supply to the damaged area increases, and blood plasma passes out of the leaky vessels into the interstitial fluid of the affected tissues, causing inflammation.
- Tissue is injured (here by a pin) and bacteria enter. Damaged cells release chemical signals such as histamine.
- Histamine makes the local blood vessels dilate and leak, so blood supply to the area increases.
- Plasma and phagocytes move out of the vessels into the tissue fluid; the tissue swells.
- Phagocytes (macrophages and neutrophils) consume bacteria and cell debris and the tissue heals.
Function of inflammation
- Eliminate the initial cause of cell injury.
- Clear out necrotic cells and tissues damaged by the original insult (to attack physically) and by the inflammatory process.
- Initiate tissue repair.
- Help prevent the spread of infection to the surrounding tissues.
9.2.4Temperature responseOften examined
Fever or pyrexia is a body temperature raised above normal. The invading microorganisms often release certain chemicals, generally termed pyrogens. Pyrogens cause the temperature set point of the hypothalamic thermostat of the body to rise. As a result all the mechanisms for raising body temperature are brought into play, such as heat conservation and increased heat production.
Certain white blood cells, in response to infection, also release hormones collectively called endogenous pyrogens. These further increase the temperature set point of the hypothalamus, because a higher body temperature increases the activity of the phagocytic white blood cells that attack bacteria.
Ways fever affects microbes
- Higher body temperature increases the activity of phagocytic white blood cells that attack bacteria.
- The endogenous pyrogens cause other cells to reduce the concentration of iron in the blood. Many bacteria need more iron to reproduce at 38 or 39 degrees Celsius than at 37 degrees Celsius, so fever and reduced iron combine to slow down their rate of reproduction.
- Fever increases the production of interferons, which travel to other cells and increase their resistance to viral attack.
- The higher temperature may directly inactivate virus particles, particularly enveloped viruses, which are more heat-sensitive than non-enveloped viruses.
- Replication of some viruses is reduced at higher temperatures, so fever may inhibit replication.
| Cause of the rise in set point | Where it comes from |
|---|---|
| Pyrogens | Released by the invading microorganisms |
| Endogenous pyrogens | Released by certain white blood cells in response to infection |
Fever is a nonspecific defence against microbial infections. However, a high degree of fever often becomes destructive to the body's own metabolic system and can ultimately collapse the body. Therefore physicians prescribe antipyretic drugs to patients with a high degree of fever.
9.3Third line of defence: the specific defencesOften examined
If a pathogen gets past the body's nonspecific defence, the third line of defence interferes with a series of defence responses, often called immune responses, that attack the particular pathogens having specific antigens. These antigens serve as the stimulus to produce an immune response. Viruses, bacteria and other pathogens have specific antigens on their surface.
- Antigen
- A substance that stimulates an immune response. The term comes from ANTI-body GENerating substances.
- Specific defence
- The third line of defence. It responds against particular infections and acts as the most powerful means of resisting infections.
The response of the third line of defence can be of two types: the humoral immune response and the cell-mediated immune response. These responses are carried out by two components: B lymphocytes (B cells) and T lymphocytes (T cells). The third line of defence also involves the role of monocytes (macrophages), which take part in the activation of these lymphocytes.
| Component | Part played in the third line of defence |
|---|---|
| Monocytes (macrophages, dendritic cells) | Display antigens and take part in the activation of T cells and B cells (9.3.1) |
| T cells | Cell-mediated immune response (9.3.2) |
| B cells | Humoral (antibody-mediated) immune response (9.3.3) |
Ask one question about each event: is it a barrier that keeps microbes out (first line), a nonspecific internal defence (second line), or a response aimed at one particular antigen (third line)?
| Order | Event | Line of defence | Reason |
|---|---|---|---|
| 1 | (b) The skin is breached | First (the barrier fails) | The skin is a physical barrier of the first line; the microbes get past it |
| 2 | (c) Histamine makes blood vessels leaky | Second | Inflammation is a nonspecific internal defence |
| 3 | (e) Macrophages engulf the bacteria | Second | Phagocytosis works against many kinds of microbe |
| 4 | (d) Plasma cells make antibodies | Third | Antibodies are specific to one antigen (humoral response) |
| 5 | (a) Memory B cells remain | Third | They give long-term protection against the same antigen |
The macrophages also display parts of the bacteria on their surface, which is the link that starts the third line of defence.
First line, then second line, then third line.
9.3.1Role of monocytes in third line of defenceOften examined
Monocytes are a kind of white blood cell. They circulate in the blood for one to three days and then leave the blood and come into the intercellular spaces of the tissues. In the tissues they swell and reach a larger size to become tissue macrophages or dendritic cells, which are irregular in shape with many projections.
When these cells perform phagocytosis of invaded microorganisms, after digesting them they not only display microbial antigens on their surfaces, they also secrete substances:
- Macrophages begin to secrete about 100 different compounds, including various enzymes, interferons and a protein called interleukin-1.
- The interleukin-1 secreted by macrophages activates T cells, which in turn begin to secrete interleukin-2, and interleukin-2 then activates B cells.
- Interleukin-1 also promotes a general response to injury, causing fever and activating other mechanisms that defend the body against invasion.
- Dendritic cells, after phagocytosis, become antigen-presenting cells for T cell activation.
- Monocytes circulate in the blood for 1 to 3 days, then enter the tissues.
- In the tissues they swell and become macrophages or dendritic cells.
- They phagocytose invaders, digest them and display microbial antigens on their surface (antigen-presenting cells).
- Macrophages secrete interleukin-1, which activates T cells.
- The T cells secrete interleukin-2, which activates B cells.
9.3.2Role of T cells in third line of defence (cell mediated immune response)Often examined
T cells originate from stem cells in the bone marrow. After early embryonic development, the newly forming T cells migrate to the thymus gland for processing. The thymus makes T cells immunocompetent, that is, capable of an immunological response. The immune response provided by T cells is called the cell mediated immune response.
Activation of T cells
In case of infection, macrophages perform phagocytosis of the invading microorganism and detect particular antigens (nonself molecules) of the organism. Macrophages isolate these antigens and display them on their surface with the help of their own proteins (self-protein) called major histocompatibility complex (MHC). In this way macrophages become antigen-presenting cells (APCs).
Macrophages also secrete interleukin-1, which stimulates and attracts helper T cells towards the displayed antigens. Helper T cells have a specific receptor on their surface called the T cell receptor (TCR), by which they bind with a particular antigen displayed on the APC. Interleukin-1 also stimulates the helper T cells to secrete another protein, interleukin-2, which not only compels the helper T cells to divide but also causes the proliferation of certain cytotoxic T cells and B cells.
The activation of T cells by a specific antigen is called cell-mediated immunity. The body contains millions of different T cells, each able to respond to one specific antigen.
- Major histocompatibility complex (MHC)
- The cell's own (self) proteins that macrophages use to display antigens on their surface.
- Antigen-presenting cell (APC)
- A cell, such as a macrophage, that displays antigens on its surface so that T cells can recognise them.
- T cell receptor (TCR)
- The specific receptor on a helper T cell that binds a particular antigen displayed on an APC.
- Cell-mediated immunity
- The activation of T cells by a specific antigen.
- The macrophage engulfs the microbe and breaks it down.
- An antigen (nonself molecule) from the microbe is joined with a self protein (MHC) and displayed on the macrophage surface: the macrophage is now an APC.
- A helper T cell binds the displayed antigen with its T cell receptor.
- Interleukin-1 from the macrophage stimulates the helper T cell.
- The helper T cell secretes interleukin-2, which makes it divide.
- Interleukin-2 also causes B cells and cytotoxic T cells to proliferate: B cells give humoral immunity and cytotoxic T cells attack infected cells.
9.3.2Types of T cellsOften examined
Two main categories of T cells have been identified. The first group is known as CD8 cells, because they have a surface marker designated CD8, and includes cytotoxic T cells and suppressor T cells. The second group, the helper T cells, are also known as CD4 cells because they have a surface marker designated CD4.
When T cells are activated they divide and produce four types of cells that have specific roles in the cell-mediated immune response.
- Cytotoxic T cells secrete cytotoxin, which triggers destruction of the pathogen's DNA, or perforin, a protein that creates holes in the pathogen's plasma membrane. The holes cause the pathogen to lyse (rupture).
- Helper T cells secrete interleukin-2, which stimulates cell division of T cells and B cells. In other words, these cells recruit even more cells to help fight the pathogen.
- Suppressor T cells: when infection is successfully removed, these cells begin to secrete certain proteins that inhibit further proliferation of T cells. Therefore they shut down the immune response.
- Memory T cells remain dormant after the initial exposure to an antigen. If the same antigen presents itself again, even years later, the memory cells are stimulated to convert themselves into helper T cells and help fight the pathogen.
| Type of T cell | Surface marker | Main action |
|---|---|---|
| Cytotoxic T cell | CD8 | Kills infected cells with cytotoxin or perforin |
| Helper T cell | CD4 | Secretes interleukin-2 to stimulate T cells and B cells |
| Suppressor T cell | CD8 | Secretes proteins that shut down the immune response |
| Memory T cell | (not stated) | Remains dormant; converts into helper T cells if the antigen returns |
| Cytotoxic T cell | Suppressor T cell |
|---|---|
| CD8 cell | CD8 cell |
| Active while the infection is present | Acts when the infection has been removed |
| Secretes cytotoxin or perforin | Secretes proteins that inhibit proliferation of T cells |
| Destroys the pathogen or infected cell | Shuts down the immune response |
Use the same four headings for each killer: what it attacks, what it releases, what the release does, and how the target ends.
| NK cell | Cytotoxic T cell | Complement system | |
|---|---|---|---|
| Attacks | Cancer cells and virus-infected body cells | Pathogen or infected cell (cell-mediated response) | Bacteria and other pathogens |
| Releases or forms | Perforins and granzymes | Cytotoxin or perforin | Membrane attack complex (MAC) of complement proteins |
| Effect | Perforin makes holes; granzymes enter and cause apoptosis | Perforin makes holes in the plasma membrane | MAC makes holes in the cell wall and plasma membrane |
| End | Cell dies by apoptosis; macrophage digests it | Pathogen lyses (ruptures) | Water and salts enter, the bacterium swells and bursts |
All three use holes in a membrane, but NK cells belong to innate immunity, cytotoxic T cells to adaptive (cell-mediated) immunity, and complement is a group of protective blood proteins of the second line.
Common feature: pore-forming proteins punch holes in the target.
9.3.3Role of B cells in third line of defence: humoral or antibody mediated immune responseOften examined
Stimulated helper T cells secrete interleukin-2, which causes the proliferation of cytotoxic T cells and B cells. B cells are differentiated in the bone marrow. B cells express specific receptors on their cell membrane, the B cell receptors (BCRs). A BCR allows the B cell to bind a specific antigen, against which it will start an antibody response. Like T cells, there are millions of B cell types in the body, each specific for one particular antigen.
| Cell-mediated immune response | Antibody-mediated (humoral) immune response |
|---|---|
| Carried out by T cells | Carried out by B cells |
| T cells differentiate in the thymus | B cells are differentiated in the bone marrow |
| T cell receptor (TCR) binds the antigen on an APC | B cell receptor (BCR) binds the antigen |
| Cytotoxic T cells attack infected cells directly | Plasma cells secrete antibodies into the blood |
| Memory T cells remain | Memory B cells remain |
9.3.3Activation of B cellsOften examined
B cell activation begins when the B cell binds to an antigen via its BCR. B cells are stimulated to bind the specific antigen by interleukin-2 proteins secreted by helper T cells. After binding a specific type of antigen, the B cell divides to produce two types of cells: plasma clone cells and memory B cells.
- Plasma cells are specialised to secrete antibodies in bulk. After B cells become plasma cells they live only for a few days, but they secrete a great deal of antibody during that time. A plasma cell can produce more than 10 million antibody molecules per hour.
- Memory B cells: if the same antigen enters the body later, the memory B cells divide to make more plasma cells and memory cells that can protect against future attacks by the same antigen.
The stimulation of B cells to divide into plasma clone cells and memory B cells, and the secretion of antibodies by plasma clone cells, is called the humoral mediated immune response.
| Plasma cells | Memory B cells |
|---|---|
| Produced when an activated B cell divides | Produced when an activated B cell divides |
| Specialised to secrete antibodies in bulk | Do not secrete bulk antibody |
| Live only a few days | Long-lived |
| Give the immune response of the current infection | Divide to make more plasma cells and memory cells if the same antigen enters again, giving future immunity |
- (a) Multiply the rate by the hours in a day.
- (b) Multiply the daily amount by 3 days.
- (c) Each antibody can hold two antigens, so double the number of molecules.
The figure is a minimum because the book says "more than 10 million". It shows why plasma cells, although short-lived, give a large quantity of antibody.
2.4 × 108 per day; 7.2 × 108 in 3 days; 4.8 × 108 antigens at most
9.3.3Structure of an antibodyOften examined
Antibodies (also called immunoglobulins or Ig) are Y-shaped proteins that circulate through the bloodstream and bind to specific antigens, thereby attacking microbes. The antibodies are transported through the blood and the lymph to the site of pathogen invasion.
A typical antibody is a Y-shaped molecule made of four polypeptide chains: two identical long chains called heavy chains and two identical short chains called light chains. Each chain has a constant segment, a functional segment and a variable segment.
- In the constant segment (C) of the heavy chains, the amino acid sequence is constant within a particular immunoglobulin class.
- The variable segments (V) consist of different amino acid sequences in every antibody. Therefore they act as the antigen-binding site.
- Each antibody has two antigen-binding sites.
- Antibody (immunoglobulin, Ig)
- A Y-shaped protein of two heavy and two light polypeptide chains that binds a specific antigen.
- Constant segment
- Part of a chain whose amino acid sequence is the same within one immunoglobulin class.
- Variable segment
- Part of a chain whose amino acid sequence differs in every antibody; it forms the antigen-binding site.
| Antibody | Antigen |
|---|---|
| A Y-shaped protein (immunoglobulin) made of four polypeptide chains | A foreign substance, often on the surface of a pathogen, that stimulates an immune response |
| Made by plasma cells | Present on viruses, bacteria and other pathogens |
| Binds to a specific antigen at its variable segments | Is bound by the antibody |
| Attacks microbes | Triggers the immune response |
9.3.3Mode of action of an antibodyOften examined
Antibodies work in four different ways.
- Neutralisation: antibodies combine with a virus or toxin and neutralise it. This prevents the binding of pathogens to host cells.
- Opsonisation: the antibody binds to an antigen, forming an antigen-antibody complex that promotes phagocytosis by macrophages.
- Complement fixation: antibodies can activate the complement system to form the membrane attack complex (MAC). As a result the target cell either bursts or undergoes phagocytosis.
- Antibody dependent cell mediated cytotoxicity (ADCC): antibodies attach to virus-infected cells or tumour cells; NK cells attach to the target cell and induce apoptosis to kill it.
| Mode | What the antibody does | Result |
|---|---|---|
| Neutralisation | Binds virus and toxins | Prevents pathogen-host binding |
| Opsonisation | Forms antigen-antibody complex | Phagocytosis by macrophages |
| Complement fixation | Activates complement to make the MAC | Phagocytosis or lysis of the target |
| ADCC | Attaches to infected or tumour cells so NK cells can bind | NK-induced apoptosis |
9.3.3Primary and secondary immune responseOften examined
The action of the immune system can be classified into two parts: the primary and the secondary immune response. The primary immune response is the first contact of the immune system with an infectious agent. All following contacts with the same pathogen are called the secondary immune response.
- The secondary immune response is faster and stronger than the primary response.
- The primary response forms memory cells, while the secondary response uses existing memory cells.
- The primary response sets the stage for the secondary response, allowing the immune system to "remember" and mount a more effective defence against future infections.
| Primary immune response | Secondary immune response |
|---|---|
| First contact of the immune system with the infectious agent | All later contacts with the same pathogen |
| Slower and weaker; antibody peak about 7 days after infection or vaccination | Faster and stronger; antibody peak about 3 days after exposure and much higher |
| Forms memory cells | Uses existing memory cells |
| Sets the stage for the secondary response | Gives long-term protection |
- The first dose is the first contact with the antigen, so it gives a primary response: it is slow and low, and it forms memory cells.
- Memory B cells remain after the antigen has gone.
- The booster is a second contact with the same antigen. It is a secondary response, which uses the existing memory cells.
- The memory cells divide quickly into many plasma cells, so antibodies appear sooner (peak about 3 days, against about 7 days) and the peak is higher.
- So the booster gives a quicker and stronger production of antibody and long-lasting protection.
The point to write in an answer: the primary response sets the stage for the secondary response, so the immune system "remembers".
Memory cells from the first dose make the second response faster and stronger.
9.3.3Monoclonal antibodyOften examined
Whenever a person falls ill, the body responds by producing antibodies to counteract the antigens of the pathogen. These antibodies are specific to a particular antigen. Scientists can replicate these antibodies and use them in the treatment of a disease. Monoclonal antibodies (mAbs) are artificially engineered in laboratories by scientists as a form of medication. They help the human body combat diseases better because each can target only one specific type of antigen.
The discovery of mAbs by Köhler and Milstein in 1975 revolutionised various aspects of biological research, diagnostics and therapy. mAbs are a single type of antibody produced by identical immune cells (clones). They bind specifically to a particular antigen. This uniqueness allows precise targeting and recognition of specific molecules.
- Monoclonal antibodies (mAbs)
- Antibodies of a single type, produced by identical immune cells (clones), engineered in laboratories to bind one specific antigen.
Impact on biological research
- Specificity and sensitivity: mAbs enabled researchers to detect and quantify specific molecules with precision, which helped in the study of complex biological processes.
- Immunological research: mAbs helped explain immune responses, cell signalling and antigen-antibody interactions.
- Cancer research: mAbs aided understanding of cancer cell biology, so targeted therapies and diagnostic tools were developed.
- Protein analysis: mAbs facilitated the detection and characterisation of specific proteins and increased understanding of protein function and expression.
- Drug development: mAbs are responsible for the creation of new targeted therapies of cancer and autoimmune diseases.
Impact on diagnostics
- ELISA (Enzyme Linked Immunosorbent Assay) and Western blot: mAbs enabled the development of sensitive and specific diagnostic tests such as ELISA and Western blot.
- Imaging agents: mAbs combined with radioactive or fluorescent labels help imaging techniques like PET and fluorescence microscopy. Positron Emission Tomography (PET) is a medical imaging technique that uses radioactive tracers to create 3D images of metabolic and physiological processes in the body. PET helps doctors diagnose and monitor various diseases such as cancer, neurological disorders and cardiovascular conditions.
Impact on therapy
- Targeted therapies: mAbs have revolutionised disease treatment. They are used to treat cancer, COVID-19, cardiovascular disease and autoimmune diseases.
- Immunotherapy: mAbs can make use of the immune system to combat cancer.
| Area | Examples from the book |
|---|---|
| Biological research | Specificity and sensitivity, immunological research, cancer research, protein analysis, drug development |
| Diagnostics | ELISA, Western blot, imaging agents (PET, fluorescence microscopy) |
| Therapy | Targeted therapies (cancer, COVID-19, cardiovascular and autoimmune diseases), immunotherapy |
9.3.4Inborn and acquired immunity
The two basic types of immunity are (a) inborn (innate) immunity and (b) acquired immunity. The ability of the innate immune system to kill microorganisms is not specific. The first and second lines of defence that you have already studied in this chapter are the part of innate or inborn immunity.
Highly specific protection is provided by the acquired (adaptive) part of the immune system, but it takes several days for this system to become fully functional. The two components of the acquired immune system are cell-mediated immunity and antibody mediated (humoral) immunity.
| Inborn (innate) immunity | Acquired (adaptive) immunity |
|---|---|
| Present from birth; first and second lines of defence | Develops after exposure; the third line of defence |
| Not specific: works against many microbes | Highly specific to a particular antigen |
| Acts at once | Takes several days to become fully functional |
| Found in all multicellular organisms | Unique to vertebrates |
| Skin, mucous membranes, phagocytes, NK cells, complement, interferons, inflammation, fever | Cell-mediated immunity (T cells) and humoral immunity (B cells and antibodies) |
9.4Types of acquired immunityOften examined
There are two ways to acquire adaptive immunity: (a) active immunity and (b) passive immunity. Both types may be acquired naturally or artificially. Providing immunity artificially is called immunisation.
Natural active immunity
This is the kind of immunity obtained as a result of an infection. The body manufactures its own antibodies when exposed to an infectious agent. This type of immunity is most effective and generally persists for a long time, sometimes even for life. For example, you can get measles only once in your life, as it gives lifelong natural active immunity.
Artificial active immunity
Artificial active immunity (vaccination) is achieved by injecting (or administering orally) small amounts of antigen, called the vaccine, into the body of an individual. The process is called vaccination. The antigen stimulates the body to manufacture antibodies against that antigen. Often a second dose, a booster, is given and this stimulates a much quicker production of antibody, which is long lasting and protects the individual from the disease for a considerable time. Several types of vaccine are currently in use.
Passive immunity
In passive immunity, antibodies from one individual are passed into another individual. They give immediate protection, unlike active immunity, which takes a few days or weeks to build up. However, it only provides protection against infection for a few weeks, because the antibodies are broken down by the body's natural processes, so their number slowly falls and protection is lost.
Natural passive immunity
This may be gained naturally. For example, antibodies from a mother can cross the placenta and enter her foetus. In this way they protect the baby until its own immune system is fully functional. Passive immunity may also be provided by colostrum, the first secretion of the mammary glands. The baby absorbs the antibodies through its gut.
Artificial passive immunity
Antibodies that have been formed in one individual are extracted and then injected into the blood of another individual, who may or may not be of the same species. They can be used for immediate protection if a person has been, or is likely to be, exposed to a particular disease. For example, specific antibodies used for combating tetanus and diphtheria used to be cultured in horses and injected into humans. Only antibodies of human origin are now used for humans. Antibodies against rabies and some snake venoms are also available. Antibodies against the human rhesus blood group antigen are used.
| Natural | Artificial | |
|---|---|---|
| Active (own antibodies, long lasting) | Infection, for example measles | Vaccination (vaccine, booster) |
| Passive (antibodies received, a few weeks) | Antibodies across the placenta; colostrum | Antibodies injected, for example against tetanus, diphtheria, rabies, snake venom, rhesus antigen |
| Active immunity | Passive immunity |
|---|---|
| The body makes its own antibodies | Antibodies from another individual are passed in |
| Takes a few days or weeks to build up | Gives immediate protection |
| Long lasting, sometimes for life | Lasts only a few weeks, as the antibodies are broken down |
| Natural (infection) or artificial (vaccination) | Natural (placenta, colostrum) or artificial (injected antibodies) |
Two questions decide the type. Did the person's own body make the antibodies (active) or were they received from another individual (passive)? Did it happen by natural infection or by a natural route (natural), or was it provided by medicine (artificial)?
| Case | Own antibodies? | Natural or artificial? | Type |
|---|---|---|---|
| (a) Recovery from measles | Yes | Natural (infection) | Natural active immunity |
| (b) Vaccine | Yes | Artificial | Artificial active immunity |
| (c) Colostrum | No: from the mother | Natural | Natural passive immunity |
| (d) Antivenom antibodies | No: from another individual | Artificial | Artificial passive immunity |
| (e) Antibodies across the placenta | No: from the mother | Natural | Natural passive immunity |
Active immunity takes days or weeks to build up but lasts long; passive immunity is immediate but lasts only a few weeks.
9.3.5Disorders of immune systemOften examined
Some conditions stimulate a defective immune response or destroy the immune system. They are called disorders of the immune system.
Allergies
Allergies are defective immune responses leading to chronic health conditions such as hay fever, eczema, asthma and food allergy. The immune system of allergy patients overreacts when allergens (like pollen, dust or mould) are inhaled, ingested or enter through the skin. The body starts producing a large quantity of special antibodies, IgE (immunoglobulin E). This IgE binds with basophils to release inflammatory chemicals like histamine.
Histamine increases capillary leakiness, swelling, mucus secretion, inflammation and other allergic responses. Antihistamine drugs block some of the effects of histamine, relieving the symptoms of allergies. Vaccination can be an effective treatment of allergy, especially for asthma.
- Allergens (pollen, dust, mould) are inhaled, ingested or enter through the skin.
- The immune system overreacts and produces large quantities of IgE.
- IgE binds with basophils, which release histamine.
- Histamine increases capillary leakiness, swelling, mucus secretion and inflammation: the symptoms of allergy.
Autoimmune disease
In autoimmune disease, the immune system attacks the healthy cells of the body's organs and tissues by mistake. Antibodies are produced against the body's own components and begin to destroy them. There are more than 80 types of autoimmune disease. They can affect almost any part of the body. For example:
- Some types of anaemia are caused by antibodies that destroy a person's red blood cells.
- Many cases of insulin-dependent (juvenile-onset) diabetes occur because the insulin-secreting cells of the pancreas are the victims of a misdirected immune response.
- Vitiligo is a chronic autoimmune disorder that causes patches of skin to lose pigment or colour.
Unfortunately, at present there is no way to cure autoimmune diseases. The autoimmune response can be suppressed with drugs.
| Allergy | Autoimmune disease |
|---|---|
| Overreaction to allergens such as pollen, dust and mould | Immune system attacks the body's own healthy cells by mistake |
| IgE binds basophils, which release histamine | Antibodies are made against the body's own components |
| Examples: hay fever, eczema, asthma, food allergy | Examples: some anaemias, insulin-dependent diabetes, vitiligo |
| Antihistamines relieve symptoms | No cure; the response can be suppressed with drugs |
9.3.5Transplant rejectionsOften examined
It is occasionally desirable to transplant some tissue or an organ such as the skin, kidney, heart or liver from one person to another to replace a non-functional, damaged or lost body part. In such cases there is a danger that the recipient's cells may recognise the donor's organ or tissue as being foreign. This triggers the recipient's immune mechanisms, which may act to destroy the donor tissue. Such a response is called transplant rejection.
Role of T cells in transplant rejection
The mechanism of rejection probably varies with the nature of the tissue and the degree of incompatibility. All the mechanisms require that the host helper T cells come into contact with the graft tissue's major histocompatibility complex (MHC) antigens. This contact is probably mediated by the dendritic cells of the graft tissue itself. At this point three different possibilities exist.
- In the first, antigen-specific TH cells stimulate the activation and proliferation of appropriate T cells, which then enhance a focused attack on the transplant tissue.
- In the second, responsive antigen-specific TH cells move to the graft site, where they release lymphokines. These recruit monocytes/macrophages and T cells to the graft site and maintain them at the scene while they destroy the tissue.
Role of B cells in transplant rejection
There is a third mechanism in which antibodies play a role. The responsive helper T cell interacts with the appropriate B cell clone, producing a shower of antibodies to the implanted tissue's MHC antigens. These can trigger either complement-mediated graft damage or facilitate the phagocytosis of the grafted tissue by macrophages.
| Mechanism | Cells and molecules | Effect on the graft |
|---|---|---|
| First (T cells) | Antigen-specific TH cells stimulate appropriate T cells | Focused attack on the transplant tissue |
| Second (T cells) | TH cells release lymphokines that recruit monocytes/macrophages and T cells | Recruited cells destroy the tissue |
| Third (B cells) | Helper T cell and B cell clone: antibodies to the graft's MHC antigens | Complement-mediated damage or phagocytosis by macrophages |
Immunosuppressant drugs
9.3.5STEAM activity 9.1
STEAM activity 9.1: Recognising phagocytes and lymphocytes while observing prepared slides.
The book gives only the title of this activity. Use the notes of this unit to recognise the cells you see on a prepared slide of blood.
| Cell | Group | What to remember |
|---|---|---|
| Neutrophil | Phagocyte (granulocyte) | Lobed nucleus; short-lived and mobile; engulfs microbes, releases enzymes and traps (Figure 9.6) |
| Monocyte | Phagocyte (becomes macrophage or dendritic cell) | Kidney-shaped nucleus in Figure 9.4; leaves the blood for the tissues |
| Lymphocyte (B cell, T cell, NK cell) | Lymphocyte | Large round, dark nucleus in Figure 9.4; B and T cells belong to the third line of defence, NK cells to the second |
Key terms
- Immune response
- The body's response to foreign particles, such as the production of antibodies directed against a specific antigen.
- Immunity
- The ability to resist damage from foreign substances such as microorganisms and harmful chemicals, for example toxins released by microorganisms.
- Immunology
- The study of foreign particles that can affect the living body and of the defence mechanisms the body uses to eliminate them.
- Innate immunity
- The first and second lines of defence together: nonspecific defence present from birth.
- Adaptive (acquired) immunity
- The third line of defence: the specific internal defence.
- Desquamation
- The shedding of dead skin cells, which removes attached microbes.
- Sebum
- An oily secretion of the sebaceous glands containing fatty acids that lower skin pH and are antimicrobial.
- Lysozyme
- An enzyme in sweat that breaks down bacterial cell walls.
- Vestibule
- The anterior part of the nasal cavities, which contains hairs.
- Phagocyte
- A white blood cell that destroys abnormal body cells or invaded microorganisms by engulfing them.
- Phagocytosis
- The process of engulfing and destroying cancerous cells or invaded microorganisms.
- Macrophage
- A phagocyte found in organs such as lungs, liver, spleen, kidney and lymph nodes; it engulfs microbes and acts as an antigen presenting cell.
- Dendritic cell
- A cell found in tissue in contact with the outside environment; an antigen presenting cell whose main function is the activation of T cells.
- Neutrophil
- A short-lived, mobile granulocyte that phagocytoses microbes, releases lysosomal enzymes by degranulation and releases extracellular traps.
- Antigen presenting cell (APC)
- A cell that displays parts of microbes on its surface so that other cells are informed, for example macrophages, dendritic cells and B cells.
- Interleukin-1
- A protein secreted by macrophages that activates T cells and signals the brain to raise body temperature.
- Interleukin-2
- A protein secreted by helper T cells that makes helper T cells divide and causes proliferation of cytotoxic T cells and B cells.
- Natural killer (NK) cell
- A lymphocyte of innate immunity that kills virus-infected and cancerous cells with perforins and granzymes.
- Perforin
- A protein that punches holes in the membrane of the target cell.
- Granzymes
- Apoptotic proteases that enter the target cell through perforin pores.
- Apoptosis
- Programmed cell death.
- Complement system
- More than fifty small blood proteins, made by the liver, that are activated in a chain and complement antibodies and phagocytes.
- Membrane attack complex (MAC)
- A complement product that makes holes in bacterial cell walls and plasma membranes so that the bacterium swells and bursts.
- Cytokine
- A chemical messenger that regulates cell differentiation, production and gene expression to affect immune responses.
- Interferon
- A cytokine released by virus-infected cells that interferes with viral replication and warns neighbouring cells.
- Inflammatory response
- A nonspecific defence triggered by tissue damage, with heat, pain, redness, swelling and loss of function.
- Histamine
- A chemical alarm signal released by damaged cells that makes blood vessels dilate and leak.
- Fever (pyrexia)
- A body temperature raised above normal.
- Pyrogens
- Chemicals released by invading microorganisms that raise the set point of the hypothalamic thermostat.
- Endogenous pyrogens
- Hormones released by white blood cells in response to infection that further raise the set point of the hypothalamus.
- Antipyretic
- A drug prescribed for high fever; it blocks the elevation of the hypothalamic set point.
- Antigen
- A substance that stimulates an immune response (from ANTI-body GENerating substances).
- Specific defence
- The third line of defence, the most powerful means of resisting infection.
- Humoral immune response
- The immune response in which B cells become plasma cells that secrete antibodies.
- Cell-mediated immune response
- The immune response carried out by T cells.
- Major histocompatibility complex (MHC)
- The cell's own (self) proteins used to display antigens on the surface of antigen presenting cells.
- T cell receptor (TCR)
- The receptor on a helper T cell that binds a particular antigen displayed on an APC.
- Immunocompetent
- Capable of an immunological response; T cells become so in the thymus.
- Cytotoxic T cell
- A CD8 cell that kills infected cells with cytotoxin or perforin.
- Helper T cell
- A CD4 cell that secretes interleukin-2 to stimulate T cells and B cells.
- Suppressor T cell
- A CD8 cell that secretes proteins that inhibit proliferation of T cells and shut down the immune response.
- Memory T cell
- A dormant cell that converts into helper T cells when the same antigen returns.
- B cell receptor (BCR)
- The specific receptor on a B cell that binds one antigen.
- Plasma cell
- An activated B cell specialised to secrete antibodies in bulk.
- Memory B cell
- A long-lived cell that divides into plasma cells and memory cells if the same antigen enters again.
- Antibody (immunoglobulin)
- A Y-shaped protein of two heavy and two light chains that binds a specific antigen.
- Opsonisation
- Binding of antibody to an antigen so that macrophages phagocytose it.
- Antibody dependent cell mediated cytotoxicity (ADCC)
- Killing of antibody-coated infected or tumour cells by NK cells, which induce apoptosis.
- Primary immune response
- The first contact of the immune system with an infectious agent; it forms memory cells.
- Secondary immune response
- All later contacts with the same pathogen; faster and stronger, using existing memory cells.
- Monoclonal antibodies (mAbs)
- Antibodies of a single type produced by identical immune cells (clones) and engineered to bind one antigen.
- Active immunity
- Immunity in which the body makes its own antibodies.
- Passive immunity
- Immunity in which antibodies from one individual are passed into another; protection lasts a few weeks.
- Vaccination
- Injecting or giving orally small amounts of antigen (a vaccine) to give artificial active immunity.
- Colostrum
- The first secretion of the mammary glands, which gives the baby natural passive immunity.
- Allergy
- A defective immune response to allergens, with IgE binding basophils to release histamine.
- Autoimmune disease
- A disease in which the immune system attacks the body's own healthy cells by mistake.
- Transplant rejection
- The destruction of donor tissue by the recipient's immune system.
- Lymphokines
- Signalling molecules released by immune cells that coordinate the immune response.
Multiple choice questionsp. 185–186
- Athe same as memory cells
- Bformed from blood plasma
- CB cells that are actively secreting antibodyAnswer
- Dinactive T cells carried in the plasma
Plasma cells are the antibody-producing form of B cells. When a B cell meets its antigen it divides and differentiates into plasma cells, which secrete antibody in bulk (more than 10 million molecules per hour).
A is wrong because memory cells are a separate, long-lived type that stays dormant. B is wrong because the name does not mean cells made from blood plasma, and D is wrong because plasma cells are B cells, not T cells.
- Aat variable regionsAnswer
- Bat constant region
- Conly if macrophages are present
- Dboth A and C are correct
Each antibody has two antigen-binding sites, and these are formed by the variable segments (V) of the heavy and light chains. The variable segments differ from one antibody to another, which is why each antibody fits one antigen.
B is wrong because the constant segment has the same sequence within a class of immunoglobulin and does not bind the antigen. C and D are wrong because macrophages help later by phagocytosis but are not needed for antigen binding.
- Anormal body temperature
- Bhormones
- Cantigens
- Dmucous membrane and ciliaAnswer
The mucous membranes of the digestive and respiratory tracts are external barriers of the first line of defence. The cilia of the nasal cavity and airways sweep trapped dust and microbes away, and the mucus traps them. These barriers work before the immune system is needed.
Normal body temperature, hormones and antigens do not stop microbes from entering the body. Temperature rises only as a defence in fever, and antigens are the foreign molecules that the immune system responds to, not a protection.
- Ainterferon production
- Bconcentration of iron in the bloodAnswer
- Cactivity of phagocytes
- Dinflammation
Endogenous pyrogens released during infection make the body cells reduce the concentration of iron in the blood. Many bacteria need more iron to reproduce at to than at , so fever and low blood iron together slow their reproduction.
A and C are wrong because fever increases both interferon production and the activity of phagocytic white blood cells. D is wrong because inflammation is a separate response to tissue damage, and the book does not describe fever as reducing it.
- AlymphocytesAnswer
- Bmacrophages
- Cnatural killer cells
- Dred blood cells
T cells and B cells are both lymphocytes, the white blood cells of the third line of defence (specific immunity). T cells mature in the thymus, and B cells are differentiated in the bone marrow.
B and C are wrong because macrophages are phagocytes, and natural killer cells are a separate lymphocyte type that is not T or B cells. D is wrong because red blood cells carry oxygen and take no part in immunity.
- AT-cells
- Bhelper T-cells
- Cplasma cellsAnswer
- Dbursa cells
When a B cell binds its specific antigen, it divides and differentiates into plasma cells, which secrete antibodies, and memory B cells, which provide future immunity.
A and B are wrong because B cells do not become T cells; they are stimulated by helper T cells. D is wrong because bursa cells are not a cell type described in this chapter.
- Akiller T-cells
- Bmemory cellsAnswer
- Cphagocytes
- Dsuppressor cells
A booster is a second dose of the vaccine. The antigen has already been met, so the memory cells that remember it are stimulated. They divide to make more plasma cells and memory cells, which gives the faster and stronger secondary immune response.
A is wrong because killer (cytotoxic) T cells are not the direct target of a booster. C is wrong because phagocytes act without memory of the antigen, and D is wrong because suppressor cells shut the response down once the infection is removed.
- Aphagocytosis
- Bcomplement proteins
- Cperforins and granzymesAnswer
- Dantibodies
NK cells release perforins, which punch holes in the membrane of the infected or cancerous cell. Granzymes then pass through the holes and start apoptosis, so the target cell dies.
A is wrong because phagocytosis is done by macrophages and neutrophils, not by NK cells. B is wrong because complement proteins act on bacteria, and D is wrong because antibodies are made by plasma cells; NK cells use them only in antibody-dependent cytotoxicity.
- Anatural active immunity
- Bartificial active immunity
- Cnatural passive immunityAnswer
- Dartificial passive immunity
Colostrum is the first secretion of the mammary glands. It carries antibodies from the mother to the baby, who absorbs them through the gut. The baby receives ready-made antibodies, so this is passive immunity, and it is natural because it comes from the mother's body without an injection.
A and B are wrong because active immunity needs the body to make its own antibodies. D is wrong because artificial passive immunity uses antibodies injected from another individual, not antibodies given naturally in milk.
- Ameasles
- BcancerAnswer
- Canorexia
- Dhaemophilia
Monoclonal antibodies (mAbs) are used in targeted therapy and immunotherapy. The chapter names cancer among the diseases they treat, together with COVID-19, cardiovascular disease and autoimmune diseases.
A is wrong because measles is the book's example of natural active immunity, which is gained after an infection. C and D are not diseases treated with mAbs in this chapter.
- AIncreased risk of infection due to loss of chemical and physical barriersAnswer
- BDecreased risk of infection due to increased immune response
- CNo change in infection risk
- DIncreased risk of autoimmune disease
The skin is the first line of defence. Its dead outer layer (physical barrier), low pH and the antimicrobial secretions of the sebaceous and sweat glands (chemical barrier) keep microbes out. A severe burn destroys these barriers, so microbes can enter the body and infection risk rises.
B is wrong because an increased immune response does not replace the lost barriers, and C is wrong because the barriers are lost. D is not an effect the chapter links to a burn.
- AThe adaptive immune response would be enhanced
- BThe innate immune response would be impaired
- CThe adaptive immune response would be impairedAnswer
- DThere would be no impact on the immune response
Dendritic cells are antigen-presenting cells (APCs). They capture an antigen, process it and display it so that T cells can recognize it. The activation of T cells, and through them the rest of the adaptive response, depends on this presentation.
If dendritic cells cannot present antigens, the adaptive response is impaired (C). A is the opposite of the effect, B is not the main consequence because the innate defences work without antigen presentation, and D is wrong because the adaptive response depends on it.
- ATargeted killing of specific pathogens
- BAbility to phagocytose large pathogens
- CImmobilization of pathogens in a localized areaAnswer
- DActivation of complement system
A neutrophil extracellular trap (NET) is released outside the cell. Its web holds the microbes in one place, where they are exposed to the killing enzymes, so they cannot spread to other tissue.
A is wrong because neutrophils are non-specific and do not target particular pathogens. B is wrong because NETs work outside the cell rather than engulfing large pathogens. D is wrong because the complement system is a separate set of proteins.
Note. The book says that neutrophils release extracellular traps "to kill microbes". The trapping function that makes option C correct follows from the name and structure of the trap.
- AIncreased risk of bacterial infections
- BIncreased risk of viral infections and cancerAnswer
- CDecreased risk of autoimmune disease
- DNo impact on immune function
NK cells kill cells infected by viruses and cancer cells by releasing perforins and granzymes. If they cannot do this, infected and cancerous cells survive, so the risk of viral infection and cancer increases.
A is wrong because NK cells do not act mainly against bacteria, C is wrong because NK cells are not linked to autoimmune disease, and D is wrong because the book gives NK cells a clear role in immunity.
- ATo induce apoptosis in uninfected cells
- BTo destroy RNA in infected cells
- CTo activate the adaptive immune response
- DTo prevent viral replication in neighboring cellsAnswer
Interferons warn neighbouring uninfected cells. These cells destroy RNA and reduce protein synthesis, so the virus cannot replicate in them. The primary purpose is therefore to stop viral replication in the neighbouring cells.
A is wrong because apoptosis is triggered in the infected cells, not the uninfected ones. B is wrong because RNA is destroyed in the neighbouring uninfected cells. C is a secondary effect, since interferons also activate immune cells.
- AIncreased phagocytosis of bacteria
- BDecreased phagocytosis of bacteriaAnswer
- CIncreased activation of complement system
- DDecreased activation of NK cells
Opsonization is the coating of a bacterium by antibodies bound to its antigens. The coated bacterium is recognized by macrophages, which engulf it. Without opsonization, the bacteria are not marked for phagocytosis, so phagocytosis of bacteria decreases.
A is the opposite of the expected result. C and D are not linked to opsonization in the chapter; complement activation and NK cell activity are separate routes.
- AIncreased killing of virus infected cells
- BTargeted killing of cancer cellsAnswer
- CEnhanced tumor growth
- DIncreased risk of infection
Monoclonal antibodies are identical antibodies that bind one specific antigen, so they can target cancer cells. This allows targeted therapy and immunotherapy with fewer effects on normal cells.
A refers to virus-infected cells rather than cancer cells. C and D describe harmful effects, not benefits.
- AIncreased risk of skin cancer
- BDecreased risk of autoimmune disease
- CIncreased risk of infection
- DEmotional distress due to cosmetic impactAnswer
Vitiligo causes patches of skin to lose pigment. The patches are visible, the disease is chronic, and there is no way to cure autoimmune diseases at present. For most patients the main consequence is the visible cosmetic change and the distress it causes.
A, B and C are not consequences that the chapter links to vitiligo. B is also wrong because vitiligo is itself an autoimmune disease, so it does not reduce the risk of autoimmune disease.
Note. No answer key is printed for these questions. The chapter states no consequence of untreated vitiligo, so D is chosen as the only option that follows from its description of the disease.
- AIncreased risk of graft-versus-host disease
- BDecreased risk of transplant rejectionAnswer
- CIncreased risk of autoimmune disease
- DNo impact on immune function
Rejection happens because the recipient's immune cells recognize the MHC antigens of the donor tissue as foreign. An identical twin has the same MHC antigens, so the recipient's cells do not treat the graft as foreign and rejection is much less likely.
The chapter gives the first successful kidney transplant between identical twins (1954) as an example. A and C are not outcomes described for identical twin grafts, and D is wrong because the immune system still works normally, but it no longer treats the graft as a foreign object.
- AEnhanced activation of cytotoxic T-cells
- BReduced activation of immune cellsAnswer
- CIncreased production of antibodies
- DEnhanced phagocytic activity of neutrophils
Lymphokines are signalling molecules that carry messages between immune cells. For example, interleukin-1 activates helper T cells, and interleukin-2 activates B cells and cytotoxic T cells. Without them, immune cells receive fewer signals and are less activated.
A, C and D are the opposite of what the messengers do, since they promote the activation of cytotoxic T cells, antibody production and phagocytosis.
Short answer questionsp. 187
The immune response is the body's response to foreign particles such as microorganisms and the toxins they release. It is directed against a specific antigen, the foreign molecule that triggers it.
- It removes the foreign particle, for example by producing antibodies that bind the specific antigen.
- It is carried out by lymphocytes (T and B cells) and their products, mainly antibodies.
- It belongs to the third line of defence, the specific (acquired) immunity, which is the most powerful means of resisting infection.
- First line of defence: external barriers, the skin and the mucous membranes of the digestive and respiratory tracts. These keep microbes out and are non-specific.
- Second line of defence: non-specific internal defence, made of phagocytic cells (macrophages, neutrophils), natural killer cells, complement proteins, interferons, inflammation and fever.
- Third line of defence: specific (adaptive) immunity, made of T and B lymphocytes, antibodies and memory cells, which act against particular antigens.
- Sebaceous (oil) glands secrete sebum, which contains fatty acids. These lower the pH of the skin to about 5.5 and have antimicrobial properties, so many pathogens cannot grow on the skin.
- Sweat glands secrete sweat, which contains lysozyme, an enzyme that breaks down the cell walls of bacteria. Its high salt concentration dehydrates bacteria.
- Both secretions contain natural antibiotics such as lactic acid, which inhibit the growth of bacteria and fungi. The sweat also has a cooling effect on the body.
- Four polypeptide chains: two identical long heavy chains and two identical short light chains.
- Each chain has a constant segment (C), whose sequence is the same within one class of antibody, and a variable segment (V), whose sequence differs from one antibody to another.
- The variable segments of a heavy chain and a light chain together form the two antigen-binding sites, one at the tip of each arm of the Y.
- A virus-infected cell releases interferons, which act on the neighbouring uninfected cells. These cells destroy RNA and reduce protein synthesis, so the virus cannot replicate in them.
- Interferons signal the infected cell itself to undergo apoptosis, so the cell dies before the virus can finish replicating and spread.
- Interferons also prevent the virus from entering uninfected cells and from leaving the infected cell, and they activate immune cells to make an immune response.
Antibodies kill or disable pathogens in four ways:
- Neutralization: antibodies bind to viruses and toxins, which prevents them from binding to host cells.
- Opsonization: an antibody bound to an antigen coats the pathogen, so macrophages recognize it and engulf it by phagocytosis.
- Complement activation: antibodies activate the complement system, which forms the membrane attack complex. Holes form in the pathogen, it swells and either bursts or is phagocytosed.
- Antibody-dependent cell-mediated cytotoxicity: antibodies bind to virus-infected or tumour cells, and NK cells attach to them and induce apoptosis.
- The variable segments of every antibody have a different amino acid sequence, so the antigen-binding site of each antibody has its own particular shape.
- The shape of the binding site is complementary to one specific antigen, like a lock and key, so the antibody binds only to that antigen.
- Each B cell clone makes antibodies of one kind, and the body contains millions of B cell types, each specific for one antigen.
- In passive immunity the antibodies are supplied ready-made from another individual, so the recipient's own immune system is not stimulated and no memory cells are formed.
- The antibodies are broken down by the body's natural processes, so their number slowly falls.
- Protection therefore lasts only a few weeks. Active immunity lasts much longer, because the body keeps its own memory cells.
- Allergies: defective immune responses to harmless substances such as pollen, dust or food, causing hay fever, eczema, asthma or food allergy.
- Autoimmune diseases: the immune system attacks the healthy cells and tissues of the body by mistake, for example anaemias, insulin-dependent diabetes and vitiligo.
- Transplant rejection: the recipient's immune system destroys a transplanted tissue or organ, because the donor tissue carries foreign MHC antigens.
Autoimmune diseases are disorders in which the immune system attacks the body's own healthy cells, tissues or organs by mistake. Antibodies are produced against the body's own components, and these begin to destroy them. There are more than 80 types, and they can affect almost any part of the body.
- Some types of anaemia, in which antibodies destroy a person's red blood cells.
- Insulin-dependent (juvenile-onset) diabetes, in which the insulin-secreting cells of the pancreas are destroyed.
- Vitiligo, a chronic disease in which patches of skin lose their pigment.
| Feature | Sebaceous gland | Sweat gland |
|---|---|---|
| Secretion | Sebum, an oily substance that contains fatty acids | Sweat, a salty watery fluid that contains lysozyme and lactic acid |
| Effect on microbes | Fatty acids lower the skin pH to about 5.5 and have antimicrobial properties | Lysozyme breaks down bacterial cell walls; the high salt content dehydrates bacteria |
| Position | In the dermis, linked with hair follicles (Figure 9.2) | In the dermis, with a duct that opens onto the skin surface |
| Feature | Macrophage | Neutrophil |
|---|---|---|
| Type of cell | Large phagocyte formed from a monocyte | Granulocyte, a short-lived white blood cell of the granulocyte type |
| Location | Stays in tissues and organs such as lungs, liver, spleen and lymph nodes | Circulates in the blood and squeezes out into tissues to reach infection |
| Lifespan and movement | Remains in tissue for long periods; removes dead cells and debris | Highly short-lived and mobile; often dies after one phagocytic event |
| Other role | Acts as an antigen-presenting cell and secretes interleukin-1 | Releases lysosomal enzymes (degranulation) and neutrophil extracellular traps (NETs) |
| Feature | Antibody-mediated (humoral) response | Cell-mediated response |
|---|---|---|
| Cells involved | B cells, which become plasma cells | T cells: cytotoxic, helper, suppressor and memory T cells |
| Action | Plasma cells secrete antibodies into blood and lymph | Cytotoxic T cells bind the target and release perforin and cytotoxin |
| Targets | Free pathogens, viruses and toxins in body fluids | Cells infected by viruses, cancer cells and transplanted tissue |
| Molecule that recognizes antigen | Antibody (immunoglobulin) | T cell receptor on the T cell |
| Feature | Cytotoxic T cell | Suppressor T cell |
|---|---|---|
| Role | Destroys infected cells and cancer cells | Shuts down the immune response once the infection is removed |
| Action | Secretes cytotoxin or perforin, which makes holes in the target membrane and causes its destruction | Secretes proteins that inhibit further proliferation of T cells |
| Marker | CD8 surface marker | CD8 surface marker |
| Stimulated by | Interleukin-2 from helper T cells, after antigen binding | Appears when infection is successfully removed |
| Feature | Plasma cell | Memory cell |
|---|---|---|
| Origin | Formed when an activated B cell divides and differentiates | Formed from the same activated B cell clone |
| Function | Secretes large quantities of antibody, more than 10 million molecules per hour | Remains dormant; on re-exposure it divides to make plasma cells and more memory cells |
| Lifespan | Lives only for a few days, but secretes a great deal of antibody | Long-lived, and provides future immunity against the same antigen |
| Feature | Antibody | Antigen |
|---|---|---|
| Nature | Y-shaped protein (immunoglobulin) made of four polypeptide chains | Foreign molecule, such as a protein on the surface of a virus or bacterium |
| Origin | Produced by plasma cells in response to the antigen | Present on the pathogen or its toxin, and stimulates the immune response |
| Interaction | Binds the specific antigen at its variable segments, forming an antigen-antibody complex | Is recognized and bound by a specific antibody or T cell receptor |
| Feature | Inborn (innate) immunity | Acquired (adaptive) immunity |
|---|---|---|
| Components | First and second lines of defence: skin, mucous membranes, phagocytes, NK cells, complement, interferons, inflammation and fever | Third line of defence: T cells, B cells, antibodies and memory cells |
| Specificity | Non-specific; it attacks a wide range of microbes | Specific; each response is directed against a particular antigen |
| Speed and memory | Acts at once; does not form memory | Takes several days to become fully functional; forms memory |
| Distribution | Found in all multicellular organisms | Unique to vertebrates |
| Feature | Primary immune response | Secondary immune response |
|---|---|---|
| Trigger | First contact with an infectious agent, or the first vaccination | Later contact with the same pathogen |
| Speed and strength | Slower and weaker; antibody production peaks at about 7 days (Figure 9.16) | Faster and stronger; antibody production peaks at about 3 days, at a much higher level |
| Memory cells | Forms memory cells | Uses the existing memory cells to produce plasma cells quickly |
Extensive answer questionsp. 188
Structure of the skin
The skin is made of two layers. The epidermis is the outer layer of tightly packed cells. Most of its cells contain keratin, which makes them resistant to abrasion and water loss, and its outer surface consists of dead cells. The dermis is the thicker inner layer. It contains glands, hair follicles, receptors, nerves and blood vessels.
How the skin keeps microbes out
The skin is a barrier in three ways. Together these defences make unbroken skin an extremely effective block against microbial invasion.
| Barrier | Feature of the skin | How it stops microbes |
|---|---|---|
| Physical | Tightly packed epidermal cells with keratin; dead cells on the surface | Microbes cannot pass through the layer, and desquamation (shedding of dead cells) removes the microbes attached to them |
| Chemical | Sebum (fatty acids) lowers the pH to about 5.5; sweat contains lysozyme, salt and lactic acid | Acidity and antimicrobial secretions inhibit or kill bacteria and fungi, and most microbes on the skin cannot get water and nutrients |
| Immune | Macrophages, dendritic cells, mast cells and lymphocytes in the dermis | Cells in the dermis engulf microbes that get past the surface and start the immune response |
Sequence of defence
- Microbes land on the skin surface. Most cannot use the surface, because it is dry and has no water or nutrients for them.
- The low pH and the antimicrobial substances in sebum and sweat inhibit the growth of those that remain.
- Dead cells are shed (desquamation), which removes microbes that are attached to them.
- Any microbe that enters the dermis meets macrophages, dendritic cells and other immune cells, which engulf it or start the immune response.
Phagocytes
Macrophages and neutrophils are phagocytes, white blood cells that destroy bacteria by engulfing them. This process is called phagocytosis. Both are part of the second line of defence, which is non-specific.
Macrophages
Macrophages are found in tissues and organs such as the lungs, liver, spleen, kidney and lymph nodes. They attack bacteria that enter the tissue, engulf them and digest them. As they interact with microbes they display parts of the microbes on their surface, so they act as antigen-presenting cells (APCs). They also secrete proteins: some trigger the maturation of monocytes into more macrophages, interleukin-1 signals the brain to raise the body temperature, and others stimulate the specific immune response.
Neutrophils
Neutrophils are short-lived granulocytes that move quickly out of the capillaries into infected tissue, moving like amoebae with pseudopodia. They kill bacteria in three ways: phagocytosis, extracellular degranulation (release of lysosomal enzymes outside the cell) and neutrophil extracellular traps (NETs). They often die after a single phagocytic event.
Steps of phagocytosis
- The bacterium is attached to the surface of the phagocyte.
- The cell membrane engulfs the bacterium, forming a phagosome inside the cell.
- A lysosome fuses with the phagosome. Its enzymes digest the bacterium (intracellular degradation).
- The digested remains are released, or parts of the bacterium are displayed on the surface of a macrophage as antigens.
Comparison
| Feature | Macrophage | Neutrophil |
|---|---|---|
| Location | Stays in tissues and organs | Circulates in the blood and moves into infected tissue |
| Lifespan | Remains in tissue; does not circulate | Highly short-lived; often dies after one phagocytic event |
| Ways of killing | Phagocytosis and digestion inside the cell | Phagocytosis, degranulation and NETs |
| Further role | Acts as an antigen-presenting cell; secretes interleukin-1; removes dead cells | Releases lysosomal enzymes that kill microbes and cause inflammation |
What the complement system is
The complement system consists of over fifty types of small proteins. They are found in the blood, are synthesized by the liver and circulate in an inactive state. They are activated when a foreign particle enters the body. Once one complement protein is activated it activates the next, which activates others in turn, so the effect is a cascade. The end result is that phagocytes clear foreign particles and damaged material, inflammation is promoted, and the membrane attack complex (MAC) is formed.
Action against a bacterium
- Activated complement proteins form complexes that create holes in the bacterial cell wall and plasma membrane. This complex is the membrane attack complex (MAC).
- Water and salts diffuse into the bacterium through the holes, so the bacterium takes in water.
- The bacterium swells and eventually bursts.
Other functions
- The complement system helps antibodies and phagocytic cells clear microbes and damaged cells from the body.
- It promotes inflammation, which attracts additional phagocytes to the site of infection.
- It attacks the plasma membrane of the pathogen by the MAC, which is one of its protective proteins.
Note. The book prints "complementary system"; it should be "complement system".
Definition and causes
Inflammation is a major component of the non-specific defence. Any damage to tissue, whether caused by an infectious microorganism, by physical injury such as a scratch, or by an insect bite, triggers it. The response can be local, confined to a specific area of the body, or systemic (widespread).
The classical signs of inflammation are heat, pain, redness, swelling and loss of function.
Chain of events
- Tissue injury: the damaged cells release chemical alarm signals such as histamine, which mobilize the defence.
- Dilation and leakage: histamine makes the neighbouring blood vessels dilate and start to leak. The blood supply to the area increases, and blood plasma passes out of the leaky vessels into the interstitial fluid, which causes swelling. Phagocytes and fluid move into the area.
- Phagocytosis: macrophages and neutrophils migrate to the area and consume bacteria and cell debris.
- Repair: the necrotic cells and tissue debris are cleared away, and the tissue heals.
Functions of inflammation
- It eliminates the initial cause of the cell injury.
- It clears out the necrotic cells and tissues damaged by the original insult.
- It initiates tissue repair.
- It helps to prevent the spread of infection to the surrounding tissues.
Fever
Fever, or pyrexia, is a body temperature higher than normal. Invading microorganisms often release chemicals called pyrogens. Pyrogens raise the temperature set point of the hypothalamic thermostat, so all the mechanisms for raising body temperature come into play: heat conservation and increased heat production.
Certain white blood cells also respond to the infection by releasing endogenous pyrogens, which raise the set point further. Macrophages secrete interleukin-1, which also causes fever.
Steps of the temperature response
- Microbes release pyrogens (exogenous pyrogens), and infected white blood cells release endogenous pyrogens.
- The pyrogens act on the hypothalamus and raise its temperature set point.
- Heat is conserved and produced, so the body temperature rises to fever.
- The raised temperature then acts against the microbes, as shown in the table below.
Why fever helps against infection
| Effect of fever | Effect on microbes or the defence |
|---|---|
| Increased activity of phagocytic white blood cells | More bacteria are destroyed by phagocytosis |
| Increased production of interferons | Cells are better protected against viral attack |
| Reduced iron concentration in the blood | Many bacteria need more iron at 38 to 39 °C than at 37 °C, so they reproduce more slowly |
| Higher body temperature | Enveloped viruses are inactivated more readily; replication of some viruses is reduced |
Limits of fever
Fever is a non-specific defence against microbial infection, but a high fever is destructive for the body's own metabolic system, and the body can collapse. Physicians therefore prescribe antipyretic drugs to patients with high fever. These drugs inhibit prostaglandin production in the hypothalamus, which stops the set point from rising further.
Fever affects microbes in several non-specific ways. Each is linked to the higher body temperature or to the endogenous pyrogens that cause the fever.
| Way | How it affects the microbes |
|---|---|
| Raised phagocytosis | Higher temperature increases the activity of phagocytic white blood cells, so they destroy more bacteria. |
| Interferon production | More interferons are produced, which increases the resistance of other cells to viral attack. |
| Iron withdrawal | Reduced iron in the blood slows the reproduction of bacteria, because many bacteria need more iron at 38 to 39 °C than at 37 °C. |
| Direct heat effect | Higher temperature can inactivate virus particles directly, especially enveloped viruses, which are more heat-sensitive than non-enveloped viruses. |
| Slower viral replication | Replication of some viruses is reduced at higher temperatures, so fever may inhibit replication. |
Formation and transport
Monocytes are white blood cells formed in the bone marrow. They circulate in the blood for one to three days before they leave the blood and migrate into the tissues. In the tissues they swell and become tissue macrophages or dendritic cells. Through the blood, macrophages and dendritic cells are transported to the areas of the body where they are needed.
Roles in the immune system
- Phagocytosis: as macrophages in the tissues, monocytes engulf and destroy invading microorganisms and remove dead cells and debris.
- Antigen presentation: after digesting a microbe, they display its non-self antigens on their surface together with their own MHC proteins. They are then antigen-presenting cells (APCs).
- Secretion: macrophages secrete about 100 different compounds, including enzymes, interferons and interleukin-1.
- Activation of T cells: interleukin-1 attracts and stimulates helper T cells, which secrete interleukin-2. Interleukin-2 activates B cells and cytotoxic T cells.
- Fever and repair: interleukin-1 also causes fever, and macrophages help to heal wounds by removing dead cells.
Macrophages and dendritic cells compared
| Cell | Where it is found | Main role |
|---|---|---|
| Macrophage | Organs such as the lungs, liver, spleen, kidney and lymph nodes | Engulfs microbes, displays antigen and secretes interleukin-1 |
| Dendritic cell | Tissues that are in contact with the outside environment | Captures, processes and presents antigen to T cells; the main activator of T cells |
Origin and maturation
T cells originate from stem cells in the bone marrow. After early embryonic development, the newly forming T cells migrate to the thymus gland for processing. The thymus makes them immunocompetent, that is, capable of an immune response. The immune response provided by T cells is called cell-mediated immune response.
Activation of T cells
- Macrophages engulf the microbe and display its non-self antigens with MHC proteins, so they act as antigen-presenting cells. They secrete interleukin-1.
- The T cell receptor (TCR) of a helper T cell binds the displayed antigen, and interleukin-1 stimulates the helper T cell.
- The activated helper T cell secretes interleukin-2, which makes the helper T cells divide and causes the proliferation of cytotoxic T cells and B cells.
- A cytotoxic T cell binds the infected cell. Its perforin makes holes in the membrane, and an enzyme enters and promotes apoptosis, so the infected cell is destroyed.
Types of T cells
| Type | Surface marker | Role |
|---|---|---|
| Cytotoxic T cell | CD8 | Secretes cytotoxin or perforin, which destroys cells infected by viruses and cancer cells |
| Helper T cell | CD4 | Secretes interleukin-2, which stimulates the division of T cells and B cells |
| Suppressor T cell | CD8 | Shuts down the response by inhibiting further proliferation of T cells once the infection is removed |
| Memory T cell | - | Remains dormant after the first exposure; on re-exposure it converts into helper T cells and helps fight the pathogen |
Origin and receptors
B cells are differentiated in the bone marrow. They express specific B cell receptors (BCRs) on their cell membrane, which allow each B cell to bind one specific antigen. There are millions of different B cell types in the body, and each is specific for one antigen.
Activation and differentiation
- The B cell binds its specific antigen through its BCR. Activation begins when the B cell binds to the antigen.
- Helper T cells secrete interleukin-2, which stimulates the B cell to divide.
- The B cell divides to produce two types of cells: plasma clone cells and memory B cells.
- The plasma clone cells differentiate into plasma cells, which secrete antibodies into the blood stream. A plasma cell can produce more than 10 million antibody molecules per hour, but it lives only a few days.
- Memory B cells are long-lived. If the same antigen enters the body later, they divide to make more plasma cells and memory cells, which protects against future attacks.
Plasma cells and memory B cells compared
| Feature | Plasma cell | Memory B cell |
|---|---|---|
| Function | Secretes antibodies | Provides future immunity |
| Lifespan | Lives a few days | Long-lived |
| On a second exposure | Not the memory cell; it secretes antibody | Divides to make more plasma cells and memory cells |
Humoral immune response
The stimulation of B cells to divide into plasma clone cells and memory B cells, and the secretion of antibodies by the plasma clone cells, is called the humoral (antibody-mediated) immune response.
Acquired immunity can be obtained in two ways. In active immunity the body makes its own antibodies. In passive immunity antibodies are transferred from another individual. Both types may be acquired naturally or artificially. Providing immunity artificially is called immunization.
Active immunity
Natural active immunity is obtained when the body manufactures its own antibodies after exposure to an infectious agent. It is the most effective type and generally persists for a long time, sometimes for life. For example, a person gets measles only once, because it gives lifelong natural active immunity.
Artificial active immunity (vaccination) is achieved by injecting, or giving orally, small amounts of antigen, called the vaccine, into the body. The antigen stimulates antibody production. A second, booster dose gives a much quicker and stronger production of antibody, which is long lasting.
Passive immunity
Passive immunity gives immediate protection, unlike active immunity, which takes days or weeks to build up. It protects only for a few weeks, because the antibodies are broken down by the body's natural processes and their number slowly falls.
Natural passive immunity: antibodies from a mother cross the placenta into the foetus, and colostrum, the first secretion of the mammary glands, passes antibodies to the baby, who absorbs them through the gut.
Artificial passive immunity: antibodies formed in one individual are extracted and injected into another individual, who may or may not be of the same species. Examples in the chapter include antibodies against tetanus, diphtheria, rabies and some snake venoms, and antibodies against the rhesus blood group antigen. Only antibodies of human origin are now used for humans.
| Type | How it is gained | Example | Duration of protection |
|---|---|---|---|
| Natural active | Body makes antibodies after an infection | Measles, which gives lifelong immunity | Long, sometimes for life |
| Artificial active | Vaccine (antigen) injected or given orally, with a booster | Vaccination | Long lasting |
| Natural passive | Antibodies cross the placenta or pass in colostrum | Mother to foetus or baby | A few weeks |
| Artificial passive | Antibodies from another individual are injected | Antivenoms and rabies antibodies | A few weeks, but immediate protection |
Why rejection happens
A transplant is the replacement of a damaged or lost tissue or organ, such as the skin, kidney, heart or liver, from one person to another. Rejection happens because the recipient's immune system recognizes the donor tissue as foreign, since the MHC antigens of the graft are different from the recipient's own. The recipient's cells then destroy the tissue.
Role of T cells
The mechanism varies with the nature of the tissue and the degree of incompatibility, but the host helper T cells must come into contact with the graft's MHC antigens. This contact is probably mediated by the dendritic cells of the graft tissue itself. Then one of three things can happen:
- Antigen-specific helper T cells stimulate the activation and proliferation of appropriate cytotoxic T cells, which then attack the transplanted tissue.
- Responsive antigen-specific helper T cells move to the graft site and release lymphokines. These recruit monocytes, macrophages and T cells to the graft and keep them there while they destroy the tissue.
Role of B cells
In the third mechanism, the responsive helper T cell interacts with the appropriate B cell clone, which produces a shower of antibodies against the graft's MHC antigens. These can trigger complement-mediated graft damage, or they can facilitate the phagocytosis of the grafted tissue by macrophages.
| Cell | Action at the graft | Outcome |
|---|---|---|
| Cytotoxic T cells | Activated by helper T cells, they attack graft cells | Destruction of the graft tissue |
| Helper T cells and lymphokines | Recruit monocytes, macrophages and T cells to the graft | Sustained attack on the graft |
| B cells and antibodies | Antibodies to MHC antigens activate complement or aid phagocytosis | Graft damage or phagocytosis of the graft |
Why the drugs are given
Organ transplantation has become a routine procedure, because surgical techniques, tissue typing and drugs have improved. Rejection is mainly a lymphocyte response to the graft's MHC antigens. The recipient's lymphocytes recognize the graft's MHC antigens as foreign and attack the graft.
- The recipient's T cells and B cells recognize the graft as foreign and start the rejection response.
- Immunosuppressive drugs act on the lymphocytes. They more selectively inhibit the rejection of the transplanted tissue and enhance tolerance, so the graft is accepted.
Implications for his life
- Infection risk: because the immune system is weakened, the recipient is more open to infections, including sepsis.
- Blood cell changes: leukopenia (a low white blood cell count) and thrombocytopenia (a low platelet count) can occur.
- Cancer risk: lymphoma is one of the listed side effects.
- Effects on several body systems: pain, diarrhoea, skin rashes, an anaphylactic reaction, hypertension, hyperkalaemia (high blood potassium) and neurotoxicity, with tremors, seizures and hallucination.
- Tiredness: because each system is affected, the person feels weakness and gets fatigue easily.
| Area affected | Effects listed in the chapter |
|---|---|
| Immune and blood | Leukopenia, thrombocytopenia, sepsis, lymphoma |
| General and digestive | Pain, diarrhoea |
| Skin and allergy | Skin rashes, anaphylactic reaction |
| Circulation and chemistry | Hypertension, hyperkalaemia |
| Nervous system | Neurotoxicity: tremors, seizures, hallucination |
What monoclonal antibodies are
Whenever a person falls ill, the body produces antibodies against the antigens of the pathogen. Scientists can replicate these antibodies and use them in treatment. Monoclonal antibodies (mAbs) are antibodies produced by identical immune cells (clones). Each mAb is a single type of antibody, and it binds only one specific antigen. This uniqueness allows precise targeting and recognition of specific molecules.
Discovery
Köhler and Milstein discovered mAbs in 1975. Their discovery revolutionized various aspects of biological research, diagnostics and therapy.
Impact on biological research
- Specificity and sensitivity: mAbs enable researchers to detect and quantify specific molecules with precision, which helps in the study of complex biological processes.
- Immunological research: mAbs help to explain immune responses, cell signalling and antigen-antibody interactions.
- Cancer research: mAbs help in understanding cancer cell biology, so targeted therapies and diagnostic tools can be developed.
- Protein analysis: mAbs help in detecting and characterizing specific proteins, which increases understanding of protein function and expression.
- Drug development: mAbs are responsible for the creation of new targeted therapies for cancer and autoimmune diseases.
Impact on diagnostics
- ELISA (Enzyme Linked Immunosorbent Assay) and Western blot: mAbs made the development of sensitive and specific diagnostic tests possible.
- Imaging agents: mAbs combined with radioactive or fluorescent labels are used in imaging techniques such as positron emission tomography (PET) and fluorescence microscopy.
Impact on therapy
- Targeted therapies: mAbs have revolutionized the treatment of disease, including cancer, COVID-19, cardiovascular disease and autoimmune diseases.
- Immunotherapy: mAbs make use of the immune system to combat cancer.
Evaluation
The discovery is significant for three reasons, which justify why it changed so many aspects of biological research:
- Specificity: each mAb binds only one antigen, so it can single out a particular molecule, cell or pathogen.
- Uniformity: all the antibodies come from identical clones, so the same antibody can be produced again and used in repeated experiments and treatments.
- Range of use: the same tool serves research, diagnosis and therapy, from detecting specific proteins to treating cancer and COVID-19.
Overall, the discovery turned antibodies from a natural defence of the body into a precise laboratory and medical tool. This is why it is judged to be a major advance in immunology and in biological research.
FBISE 2026 questions
Questions from the FBISE HSSC-II 2026 (1st Annual) papers that belong to this unit, answered the way an examiner expects.
- ATargeted cancer therapyAnswer
- BAllergic reactions
- CDiagnosis of diseases
- DBlood transfusion reactions
Monoclonal antibodies (mAbs) bind one specific antigen, so they can be aimed at one kind of cell. The book lists targeted therapies (cancer, COVID-19, cardiovascular and autoimmune diseases) and immunotherapy under the therapeutic use of mAbs, so targeted cancer therapy is correct.
C is the tempting option, but diagnosis of diseases is a diagnostic use (ELISA, Western blot, imaging with labelled mAbs), not a therapy. B and D are not uses of mAbs at all.
- ANatural passive immunityAnswer
- BArtificial active immunity
- CNatural active immunity
- DArtificial passive immunity
The baby receives ready-made antibodies from its mother, so the baby's own immune system has not made them: the immunity is passive. It comes through the placenta without any injection or medical procedure, so it is natural. This is natural passive immunity, and it lasts only a few weeks because the antibodies are broken down.
C is the tempting option, but natural active immunity needs the body itself to make antibodies after an infection. B and D are artificial, which needs a vaccine or an injection of antibodies.
Definition (1 mark)
Macrophages are large phagocytic white blood cells formed from monocytes. Monocytes leave the blood and settle in tissues and organs such as the lungs, liver, spleen, kidney and lymph nodes, where they become macrophages. They belong to the second line of defence (nonspecific).
Two functions (2 marks)
- Phagocytosis: they engulf and destroy microorganisms that enter the tissue.
- Antigen presentation: they display parts of the microbe on their surface, so they are antigen presenting cells (APCs) and inform other cells; they secrete proteins that raise the body temperature (interleukin-1) and stimulate the specific immune response.
- Wound healing and tissue repair: they remove dead cells and debris.
T cells differentiate in the thymus. When they are activated they divide and give four types, each with its own role in the cell-mediated immune response. Any three earn the marks (1 mark each).
| Type of T cell (1 mark each) | Surface marker | Action |
|---|---|---|
| Cytotoxic T cell | CD8 | Secretes cytotoxin, which destroys the pathogen's DNA, or perforin, which makes holes in the pathogen's plasma membrane so that it lyses |
| Helper T cell | CD4 | Secretes interleukin-2, which stimulates cell division of T cells and B cells and so recruits more cells to fight the pathogen |
| Suppressor T cell | CD8 | When the infection has been removed, secretes proteins that inhibit further proliferation of T cells and shuts down the immune response |
| Memory T cell | (not stated) | Stays dormant after the first exposure; if the same antigen returns, even years later, it changes into helper T cells and helps fight the pathogen |
| Label | What it is |
|---|---|
| Antigen-binding sites | the two tips of the Y; formed by the variable segments of a heavy and a light chain |
| Variable segment (V) | different amino acid sequence in every antibody; gives the specificity |
| Constant segment (C) | amino acid sequence constant within one immunoglobulin class |
| Heavy chains | the two long chains, forming the stem and the arms of the Y |
| Light chains | the two short chains, one beside each arm |
| Feature | Active immunity | Passive immunity |
|---|---|---|
| Source of antibodies | The body makes its own antibodies after meeting the antigen | Ready-made antibodies from another individual are passed in |
| Start of protection | Slow: takes a few days or weeks to build up | Immediate protection |
| Duration | Long lasting, sometimes for life; memory cells are formed | Only a few weeks, because the antibodies are broken down by the body and their number falls |
| Natural way | Infection (for example measles) | Antibodies cross the placenta; colostrum |
| Artificial way | Vaccination (vaccine, booster dose) | Injection of antibodies (for example against tetanus, rabies, snake venom) |
- ATarget multiple antigens
- BLow cost of production
- CGreater specificity and consistencyAnswer
- DLonger shelf life
Monoclonal antibodies are a single type of antibody made by identical immune cells (clones). Each binds one specific antigen, so they give precise targeting and recognition. Their main advantage is therefore greater specificity and consistency.
A is the opposite of the truth: a monoclonal antibody targets only one type of antigen, not many. B and D (cost and shelf life) are not advantages given for mAbs in the book.
- ATransfer of plasma
- BBlood transfusion
- CExposure to antigensAnswer
- DInjection of antibodies
In active immunity the body makes its own antibodies, and this happens when the immune system meets an antigen, either in an infection (natural) or in a vaccine (artificial). So active immunity is developed by exposure to antigens.
A, B and D (plasma, blood transfusion, injected antibodies) all give ready-made antibodies from another person or animal. That is passive immunity: the body has not made the antibodies itself.
Definition (1 mark)
Monoclonal antibodies (mAbs) are antibodies of a single type, produced by identical immune cells (clones) and engineered in laboratories as a form of medication. Each mAb binds one specific antigen. They were discovered by Köhler and Milstein in 1975.
Two advantages (2 marks)
- Specific targeting: each mAb recognises only one type of antigen (for example on a cancer cell or a virus), so the treatment is aimed precisely at the target.
- Uses the body's own defence: mAbs make use of the immune system to combat disease (immunotherapy), and the same specific mAbs, joined to radioactive or fluorescent labels, can also be used to detect and image the disease.
The skin gives a physical, a chemical and an immune barrier. Any three points (1 mark each):
| Barrier | How it stops pathogens |
|---|---|
| Physical (epidermis) | Tightly packed cells containing keratin form a tough layer; the dry dead surface cells give microbes no water or nutrients; shedding of dead cells (desquamation) removes microbes attached to the surface |
| Chemical (acid and secretions) | The surface pH is acidic (about 5.5), which inhibits many pathogens; sebum has fatty acids that lower the pH; sweat contains lysozyme, which breaks down bacterial cell walls, and salt, which dehydrates bacteria; lactic acid inhibits bacteria and fungi |
| Immune (dermis) | Immune cells in the dermis (macrophages, mast cells, innate lymphoid cells, T cells) attack microbes that get through |
Note. The paper prints 'pathgens'; it should read 'pathogens'.
Complement system (1 mark)
The complement system is a group of over fifty small proteins found in the blood. They are made by the liver and circulate in an inactive state. When a foreign particle enters the body they are activated one after another, each activated protein activating the next.
Two mechanisms (2 marks)
- Membrane attack complex (MAC): activated proteins form complexes that make holes in the cell wall and plasma membrane of the bacterium. Water and salts diffuse in, so the bacterium swells and bursts.
- Help to phagocytes and inflammation: complement proteins help phagocytes to clear the foreign particles, and they promote inflammation, which attracts more phagocytes to the site of infection.
Origin and receptors (1 mark)
B cells are differentiated in the bone marrow. Each carries specific B cell receptors (BCRs) on its membrane, so it can bind one particular antigen. There are millions of B cell types in the body, each specific for one antigen.
Activation and differentiation (2 marks)
- The B cell binds its specific antigen through its BCR, and this clone is selected.
- Helper T cells secrete interleukin-2, which stimulates the B cell to divide.
- The B cell divides into plasma clone cells and memory B cells.
Result (1 mark)
- Plasma cells secrete antibodies in bulk into the blood (more than 10 million molecules per hour) but live only a few days. The antibodies neutralise viruses and toxins, promote phagocytosis (opsonisation), activate complement and take part in ADCC.
- Memory B cells are long-lived. If the same antigen enters again they divide into more plasma cells and memory cells, giving a faster and stronger secondary response.
This stimulation of B cells and the secretion of antibodies by the plasma cells is the humoral (antibody-mediated) immune response.
| Label | What it is |
|---|---|
| Antigen-binding sites | the two tips of the Y; formed by the variable segments of a heavy and a light chain |
| Variable segment (V) | different amino acid sequence in every antibody; gives the specificity |
| Constant segment (C) | amino acid sequence constant within one immunoglobulin class |
| Heavy chains | the two long chains, forming the stem and the arms of the Y |
| Light chains | the two short chains, one beside each arm |
Exam focus
- Draw and label the structural model of an antibody (heavy and light chains, variable and constant segments, antigen-binding sites). (long)Asked in both 2026 sets (Set B Q.4 (a), Set D Q.5 (b) OR); book short question 4.Go to answer
- Describe the role of B cells in the humoral immune response: BCR, interleukin-2, plasma cells and memory B cells. (long)Set D Q.5 (a) OR (4 marks); book long question 9.Go to answer
- Differentiate between active and passive immunity, and classify natural and artificial examples (colostrum, placenta, vaccination). (long)Set B Q.4 (b), MCQ 10 and Set D MCQ 11; book long question 10.Go to answer
- Monoclonal antibodies: definition, specificity and therapeutic use. (short)Set B MCQ 7, Set D MCQ 8 and Set D Q.2 (v); book long question 13.Go to answer
- Types of T cells (cytotoxic, helper, suppressor, memory) and their actions. (short)Set B Q.2 (x) OR; book short question 11 (d) and long question 8.Go to answer
- Skin as a barrier, complement system and macrophages: three-point short answers. (short)Set D Q.2 (vi) OR and Q.2 (x), Set B Q.2 (vi); book long questions 1 to 3.Go to answer
- How antibodies kill pathogens (neutralisation, opsonisation, complement fixation, ADCC) and why each antibody binds one antigen. (short)Supports the antibody-structure questions (Set B Q.4 (a), Set D Q.5 (b) OR); book short questions 6 and 7.Go to answer
- Primary and secondary immune response: memory cells and why a booster works. (short)No direct 2026 question; the book's graph and short question 11 (h) make it a likely 3-mark question.Go to answer